Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	benzodiazepine receptor binding	RIMBP3 RIMBP3C RIMBP3B	5.88e-06	5	169	3	GO:0030156
GeneOntologyMolecularFunction	actin binding	MYH6 MYH7 MYO1A SPTAN1 MTSS1 CAPZA1 CAPZA2 OPHN1 XIRP2 SYNE2 LMOD1 DIAPH3 IQGAP3 EPB41L2	5.97e-05	479	169	14	GO:0003779
GeneOntologyMolecularFunction	ATP-dependent activity	DNHD1 MYH6 MYH7 SPAST MYO1A ATP8A2 WRNIP1 NVL CHD9 ATAD2 ABCA8 ORC4 ABCB10 NAV3 CCT8 HSP90AA4P	6.90e-05	614	169	16	GO:0140657
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYH7 SPAST ATP8A2 WRNIP1 NVL CHD9 ATAD2 ABCA8 ORC4 ABCB10 NAV3 CCT8 HSP90AA4P	1.01e-04	441	169	13	GO:0016887
GeneOntologyMolecularFunction	actin filament binding	MYH6 MYH7 MYO1A SPTAN1 MTSS1 CAPZA1 CAPZA2 XIRP2 IQGAP3	1.40e-04	227	169	9	GO:0051015
GeneOntologyBiologicalProcess	actin filament-based process	MYH6 MYH7 STARD8 MYO1A MYOM1 SPTAN1 MTSS1 CAPZA1 CAPZA2 CDC42BPB OPHN1 CYFIP2 XIRP2 ARHGEF7 SYNE2 STAU2 MKLN1 LMOD1 TAC1 DIAPH3 QKI IQGAP3 EPB41L2	1.80e-06	912	170	23	GO:0030029
GeneOntologyBiologicalProcess	actin cytoskeleton organization	MYH6 MYH7 STARD8 MYO1A MYOM1 SPTAN1 MTSS1 CAPZA1 CAPZA2 CDC42BPB OPHN1 CYFIP2 XIRP2 ARHGEF7 STAU2 MKLN1 LMOD1 TAC1 DIAPH3 IQGAP3 EPB41L2	3.01e-06	803	170	21	GO:0030036
GeneOntologyBiologicalProcess	regulation of protein depolymerization	SPAST SPTAN1 CAPZA1 CAPZA2 NAV3 LMOD1 DIAPH3	2.64e-05	105	170	7	GO:1901879
GeneOntologyBiologicalProcess	postsynapse organization	SEMA3F ZMYND8 GRID1 GRIN2A ADAM10 OPHN1 CYFIP2 IL1RAPL1 ARHGEF7 STAU2 DCLK1	5.99e-05	313	170	11	GO:0099173
GeneOntologyBiologicalProcess	regulation of supramolecular fiber organization	SPAST SPTAN1 MTSS1 CAPZA1 CAPZA2 CYFIP2 XIRP2 ARHGEF7 NAV3 LMOD1 TAC1 DIAPH3 PFDN6	7.27e-05	438	170	13	GO:1902903
GeneOntologyBiologicalProcess	negative regulation of protein depolymerization	SPTAN1 CAPZA1 CAPZA2 NAV3 LMOD1 DIAPH3	9.47e-05	89	170	6	GO:1901880
GeneOntologyBiologicalProcess	supramolecular fiber organization	KRT4 MYH6 MYH7 SPAST MYO1A MYOM1 SPTAN1 DDR2 MTSS1 CAPZA1 CAPZA2 CYFIP2 XIRP2 ARHGEF7 NAV3 LMOD1 TAC1 DIAPH3 PFDN6 IQGAP3	1.26e-04	957	170	20	GO:0097435
GeneOntologyBiologicalProcess	regulation of postsynapse organization	SEMA3F ZMYND8 GRID1 ADAM10 CYFIP2 IL1RAPL1 STAU2 DCLK1	1.53e-04	185	170	8	GO:0099175
GeneOntologyBiologicalProcess	cell projection assembly	DNHD1 STK36 MYO1A TTC39C KIAA0586 MTSS1 ZMYND8 ODAD2 IFT43 OPHN1 CYFIP2 FSIP2 ODF2L ARHGEF7 SYNE2 STAU2	1.80e-04	685	170	16	GO:0030031
GeneOntologyBiologicalProcess	negative regulation of protein-containing complex disassembly	SPTAN1 CAPZA1 CAPZA2 NAV3 LMOD1 DIAPH3	1.80e-04	100	170	6	GO:0043242
GeneOntologyBiologicalProcess	protein depolymerization	SPAST SPTAN1 CAPZA1 CAPZA2 NAV3 LMOD1 DIAPH3	1.95e-04	144	170	7	GO:0051261
GeneOntologyBiologicalProcess	regulation of protein-containing complex disassembly	SPAST SPTAN1 CAPZA1 CAPZA2 NAV3 LMOD1 DIAPH3	1.95e-04	144	170	7	GO:0043244
GeneOntologyCellularComponent	cell cortex	ARHGAP32 MYO1A SPTAN1 CAPZA1 CAPZA2 RYR1 HMCN2 ARHGEF7 INSC CSNK1G2 MKLN1 IQGAP3 EPB41L2	1.29e-05	371	172	13	GO:0005938
GeneOntologyCellularComponent	actin cytoskeleton	ARHGAP32 MYH6 MYH7 MYO1A SPTAN1 DDR2 MTSS1 CAPZA1 CAPZA2 CDC42BPB OPHN1 XIRP2 LMOD1 DIAPH3 EPB41L2	8.71e-05	576	172	15	GO:0015629
Domain	AAA	SPAST WRNIP1 NVL ATAD2 ORC4 NAV3	5.89e-06	52	163	6	PF00004
Domain	ATPase_AAA_core	SPAST WRNIP1 NVL ATAD2 ORC4 NAV3	7.36e-06	54	163	6	IPR003959
Domain	AAA	SPAST WRNIP1 NVL ATAD2 ABCA8 ORC4 ABCB10 NAV3	3.90e-05	144	163	8	SM00382
Domain	AAA+_ATPase	SPAST WRNIP1 NVL ATAD2 ABCA8 ORC4 ABCB10 NAV3	3.90e-05	144	163	8	IPR003593
Domain	ATPase_AAA_CS	SPAST WRNIP1 NVL ATAD2	1.12e-04	29	163	4	IPR003960
Domain	AAA	SPAST WRNIP1 NVL ATAD2	2.11e-04	34	163	4	PS00674
Domain	F_ACTIN_CAPPING_A_1	CAPZA1 CAPZA2	2.26e-04	3	163	2	PS00748
Domain	F_ACTIN_CAPPING_A_2	CAPZA1 CAPZA2	2.26e-04	3	163	2	PS00749
Domain	F-actin_cap_A	CAPZA1 CAPZA2	2.26e-04	3	163	2	PF01267
Domain	CapZ_alpha	CAPZA1 CAPZA2	2.26e-04	3	163	2	IPR002189
Domain	F-actin_cap_asu_CS	CAPZA1 CAPZA2	2.26e-04	3	163	2	IPR017865
Pathway	REACTOME_RHOJ_GTPASE_CYCLE	ARHGAP32 CDC42BPB OPHN1 ARHGEF7 DIAPH3 IQGAP3	5.14e-06	55	114	6	M41815
Pathway	REACTOME_RHOQ_GTPASE_CYCLE	ARHGAP32 CDC42BPB OPHN1 ARHGEF7 DIAPH3 IQGAP3	7.04e-06	58	114	6	MM15602
Pathway	REACTOME_RHOQ_GTPASE_CYCLE	ARHGAP32 CDC42BPB OPHN1 ARHGEF7 DIAPH3 IQGAP3	7.79e-06	59	114	6	M41812
Pathway	REACTOME_RHOB_GTPASE_CYCLE	ARHGAP32 STARD8 OPHN1 STK10 DIAPH3 IQGAP3	1.94e-05	69	114	6	MM15596
Pathway	REACTOME_RHOB_GTPASE_CYCLE	ARHGAP32 STARD8 OPHN1 STK10 DIAPH3 IQGAP3	2.11e-05	70	114	6	M41806
Pathway	REACTOME_RHOA_GTPASE_CYCLE	ARHGAP32 STARD8 OPHN1 STK10 ARHGEF7 DIAPH3 IQGAP3	1.52e-04	142	114	7	MM15576
Pathway	REACTOME_RHOA_GTPASE_CYCLE	ARHGAP32 STARD8 OPHN1 STK10 ARHGEF7 DIAPH3 IQGAP3	2.05e-04	149	114	7	M41805
Pathway	REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3	RAB9B ARHGAP32 STARD8 AHCTF1 SPTAN1 PIK3R3 KLC4 CDC42BPB OPHN1 CYFIP2 STK10 RAB9A ARHGEF7 DIAPH3 IQGAP3	2.27e-04	649	114	15	MM15690
Pathway	REACTOME_RHOC_GTPASE_CYCLE	ARHGAP32 OPHN1 STK10 DIAPH3 IQGAP3	2.52e-04	70	114	5	MM15597
Pathway	REACTOME_CDC42_GTPASE_CYCLE	ARHGAP32 STARD8 CDC42BPB OPHN1 ARHGEF7 DIAPH3 IQGAP3	2.61e-04	155	114	7	M41808
Pathway	REACTOME_RHOC_GTPASE_CYCLE	ARHGAP32 OPHN1 STK10 DIAPH3 IQGAP3	3.27e-04	74	114	5	M41807
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DNAJC13 ZMYND8 CHD9 TAB2 NBEA EZH1 CYFIP2 KCND2 GCC2 SYNE2 DCLK1	7.20e-13	87	174	11	12465718
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYH7 HIVEP1 MYOM1 PSMD1 TAB2 PCDH12 KMT2E SUCLG2 CDC42BPB RYR1 KARS1 ATXN1 XIRP2 SYNE2 MKLN1 MED12L ACAA2	6.47e-10	497	174	17	23414517
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	ARHGAP32 SPTAN1 CAPZA2 ADGRB3 NBEA GRIN2A FAM81A CYFIP2 ARHGEF7 PLCB1 DCLK1 EPB41L2	5.96e-09	251	174	12	27507650
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	MYH6 MYH7 MYO1A SPTAN1 CAPZA1 CAPZA2 PSMD1 SUCLG2 LGALS3BP ABCB10 CCT8 UBR3 EIF3F FKBP8 PZP IQGAP3	1.88e-07	647	174	16	26618866
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	GPC1 MTA2 DPP6 ARHGAP32 MYH6 DNAJC13 TRIM25 SPTAN1 RBP3 CAPZA1 CAPZA2 WRNIP1 NBEA GRIN2A CDC42BPB OPHN1 CYFIP2 NPTN KARS1 SF3B3 CCT8 DCLK1 EPB41L2 IGHV3-73	2.23e-07	1431	174	24	37142655
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	ARHGAP32 SPAST SPTAN1 WRNIP1 ADGRB3 PSMD1 NBEA GRIN2A MCCC1 CDC42BPB KCND2 ARHGEF7 STAU2 MKLN1 NAV3 PLCB1 CCT8 UBR3 FKBP8 DCLK1 EPB41L2	2.98e-07	1139	174	21	36417873
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ARHGAP32 DNAJC13 SPTAN1 CAPZA2 ADGRB3 NBEA GRIN2A CDC42BPB FAM81A CYFIP2 HIRA NPTN ARHGEF7 SYNE2 PLCB1 CCT8 DCLK1 AFF4 EPB41L2	4.15e-07	963	174	19	28671696
Pubmed	RIM-BP3 is a manchette-associated protein essential for spermiogenesis.	RIMBP3 RIMBP3C RIMBP3B	4.91e-07	4	174	3	19091768
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	MTA2 DNHD1 GAPVD1 RIOK1 HIVEP1 TRIM25 DIABLO SPTAN1 KIAA0586 CAPZA1 CAPZA2 BAZ1B PSMD1 ATAD2 CYFIP2 RAB9A KARS1 SF3B3 CCT8 ATM IQGAP3 NXF1 EPB41L2	7.91e-07	1425	174	23	30948266
Pubmed	Structure and evolution of RIM-BP genes: identification of a novel family member.	RIMBP3 RIMBP3C RIMBP3B	1.22e-06	5	174	3	17855024
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	GPC1 MTA2 DNAJC13 MIS18BP1 TRIM25 AHCTF1 SPTAN1 CAPZA1 CAPZA2 BAZ1B PSMD1 MCCC1 SUCLG2 ATAD2 HIRA KARS1 SF3B3 CCT8 ACAA2 EIF3F NXF1 EPB41L2	1.24e-06	1353	174	22	29467282
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ARHGAP32 GAPVD1 HIVEP1 SPAST KLHDC2 SPTAN1 TAB2 MCCC1 KLC4 CARD8 CDR2L FSIP2 ATXN1 SYNE2 DCLK1 BICC1 EPB41L2	1.73e-06	861	174	17	36931259
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	MIS18BP1 HIVEP1 RNASEH2A CAPZA1 CAPZA2 BAZ1B TAB2 MCCC1 RIMBP3 ODF2L SF3B3 DIAPH3 NXF1 SORL1	1.76e-06	588	174	14	38580884
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	MTA2 TSHZ3 RNF169 MIS18BP1 HIVEP1 AHCTF1 NVL BAZ1B CHD9 ATAD2 HIRA FSIP2 ORC4 AFF4	2.59e-06	608	174	14	36089195
Pubmed	STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.	RIOK1 SAMD9 SPTAN1 NVL IFNB1 KARS1 SF3B3 CCT8 EIF3F NXF1	4.82e-06	316	174	10	31665637
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ARHGAP32 DUSP18 RNF169 DNAJC13 SPTAN1 PIK3R3 SCYL3 PSMD1 TAB2 NBEA CDC42BPB CYFIP2 KARS1 SYNE2 VPS13A UBR3 FKBP8 PFDN6	5.97e-06	1049	174	18	27880917
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	RNF169 TRIM25 PIEZO1 AHCTF1 ZMYND8 BAZ1B ATAD2 CDC42BPB CYFIP2 HIRA ORC4 KMT2C CSNK1G2 STAU2 CCT8 EIF3F FKBP8 IQGAP3 DCLK1 NXF1 AFF4 EPB41L2	6.31e-06	1497	174	22	31527615
Pubmed	A long noncoding RNA protects the heart from pathological hypertrophy.	MYH6 MYH7 GTF2B	6.77e-06	8	174	3	25119045
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	STK36 ARHGAP32 RNF169 STARD8 KIAA0586 ZBTB26 CDC42BPB ABCA8 FAT2 CCT8 UBR3 DDHD2	7.91e-06	493	174	12	15368895
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	DNAJC13 RIOK1 SPTAN1 CAPZA1 WRNIP1 PSMD1 ORC4 SF3B3 MED12L CCT8 ATM DIAPH3 DEPDC7	8.26e-06	582	174	13	20467437
Pubmed	The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation.	MTA2 RIOK1 ZMYND8 CAPZA1 WRNIP1 NVL RUNX3 SF3B3 ATXN1 CCT8 EIF3F DCLK1 EPB41L2	8.41e-06	583	174	13	29844126
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TSHZ3 GAPVD1 DNAJC13 HIVEP1 ZMYND8 PSMD1 MCCC1 GCC2 CCT8 DIAPH3 NXF1	9.25e-06	418	174	11	34709266
Pubmed	Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling.	ARHGAP32 SPTAN1 NBEA GRIN2A FAM81A CYFIP2 NPTN DCLK1 EPB41L2	1.32e-05	281	174	9	28706196
Pubmed	EZH2 interacts with HP1BP3 to epigenetically activate WNT7B that promotes temozolomide resistance in glioblastoma.	GPC1 MTA2 DNAJC13 SAMD9 CAPZA1 CAPZA2 PSMD1 EZH1 SUCLG2 LGALS3BP SF3B3 CCT8 EIF3F FKBP8 DCLK1	1.39e-05	803	174	15	36517590
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	MTA2 RNF169 MIS18BP1 TRIM25 ZMYND8 WRNIP1 NVL BAZ1B CHD9 RUNX3 GTF2B KARS1 SF3B3 CCT8 ATM EIF3F NXF1	1.48e-05	1014	174	17	32416067
Pubmed	Large-scale proteomics and phosphoproteomics of urinary exosomes.	DNHD1 DNAJC13 SPAST PDE8A AHCTF1 CAPZA1 CAPZA2 GRID1 IRF6 PKD1L3 ATAD2 CDC42BPB RYR1 CYFIP2 LGALS3BP CCT8 SORL1	1.51e-05	1016	174	17	19056867
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DNAJC13 TRIM25 PIEZO1 AHCTF1 SPTAN1 PIK3R3 NVL BAZ1B CDC42BPB LGALS3BP SF3B3 ABCB10 SYNE2 STAU2 VPS13A ATM DIAPH3 FKBP8 DDHD2 PFDN6 EPB41L2	1.88e-05	1487	174	21	33957083
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	GPC1 MTA2 KRT4 SAMD9 TRIM25 AHCTF1 SPTAN1 CAPZA1 CAPZA2 BAZ1B LGALS3BP KARS1 SF3B3 STAU2 CCT8 EIF3F IQGAP3 NXF1 EPB41L2	1.93e-05	1257	174	19	36526897
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	MTA2 MYH7 RIOK1 SPTAN1 CAPZA1 CAPZA2 PSMD1 TAB2 CYFIP2 KARS1 SF3B3 LRRIQ1 STAU2 CCT8 EIF3F PFDN6 IQGAP3 EPB41L2	2.02e-05	1149	174	18	35446349
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ARHGAP32 FAT4 HIVEP1 TAB2 NBEA RYR1 IL1RAPL1 GCC2 SYNE2 VPS13A PLCB1 LMOD1 PFDN6	2.17e-05	638	174	13	31182584
Pubmed	Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression.	MYH6 MYH7	2.49e-05	2	174	2	21526716
Pubmed	Characterization of human cardiac myosin heavy chain genes.	MYH6 MYH7	2.49e-05	2	174	2	2726733
Pubmed	Human cardiac myosin heavy chain genes and their linkage in the genome.	MYH6 MYH7	2.49e-05	2	174	2	3037493
Pubmed	β-myosin heavy chain is induced by pressure overload in a minor subpopulation of smaller mouse cardiac myocytes.	MYH6 MYH7	2.49e-05	2	174	2	21778428
Pubmed	Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6).	MYH6 MYH7	2.49e-05	2	174	2	8307559
Pubmed	Molecular cloning and characterization of human cardiac alpha- and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium.	MYH6 MYH7	2.49e-05	2	174	2	2969919
Pubmed	Distribution and structure-function relationship of myosin heavy chain isoforms in the adult mouse heart.	MYH6 MYH7	2.49e-05	2	174	2	17575272
Pubmed	Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the alpha cardiac myosin heavy chain gene.	MYH6 MYH7	2.49e-05	2	174	2	9884344
Pubmed	Role of microtubules versus myosin heavy chain isoforms in contractile dysfunction of hypertrophied murine cardiocytes.	MYH6 MYH7	2.49e-05	2	174	2	12750067
Pubmed	Induction of Type I Interferon through a Noncanonical Toll-Like Receptor 7 Pathway during Yersinia pestis Infection.	TLR7 IFNB1	2.49e-05	2	174	2	28847850
Pubmed	Transgenic mouse α- and β-cardiac myosins containing the R403Q mutation show isoform-dependent transient kinetic differences.	MYH6 MYH7	2.49e-05	2	174	2	23580644
Pubmed	ATAD2 drives colorectal cancer progression by regulating TRIM25 expression via a positive feedback loop with E2F transcriptional factors.	TRIM25 ATAD2	2.49e-05	2	174	2	35085891
Pubmed	The LFA-1-associated molecule PTA-1 (CD226) on T cells forms a dynamic molecular complex with protein 4.1G and human discs large.	CD226 EPB41L2	2.49e-05	2	174	2	15138281
Pubmed	Rab9 GTPase is required for replication of human immunodeficiency virus type 1, filoviruses, and measles virus.	RAB9B RAB9A	2.49e-05	2	174	2	16140752
Pubmed	β-Myosin heavy chain variant Val606Met causes very mild hypertrophic cardiomyopathy in mice, but exacerbates HCM phenotypes in mice carrying other HCM mutations.	MYH6 MYH7	2.49e-05	2	174	2	24829265
Pubmed	Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart.	MYH6 MYH7	2.49e-05	2	174	2	2036722
Pubmed	Ensemble force changes that result from human cardiac myosin mutations and a small-molecule effector.	MYH6 MYH7	2.49e-05	2	174	2	25937279
Pubmed	Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue.	MYH6 MYH7	2.49e-05	2	174	2	15621050
Pubmed	Functional effects of the hypertrophic cardiomyopathy R403Q mutation are different in an alpha- or beta-myosin heavy chain backbone.	MYH6 MYH7	2.49e-05	2	174	2	18480046
Pubmed	Murine pulmonary myocardium: developmental analysis of cardiac gene expression.	MYH6 MYH7	2.49e-05	2	174	2	7919499
Pubmed	Long-Read Sequence Confirmed a Large Deletion Including MYH6 and MYH7 in an Infant of Atrial Septal Defect and Atrial Arrhythmias.	MYH6 MYH7	2.49e-05	2	174	2	34384224
Pubmed	Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2----q13.	MYH6 MYH7	2.49e-05	2	174	2	2494889
Pubmed	All-atom molecular dynamics simulations of actin-myosin interactions: a comparative study of cardiac α myosin, β myosin, and fast skeletal muscle myosin.	MYH6 MYH7	2.49e-05	2	174	2	24224850
Pubmed	Myosin heavy chain composition and the economy of contraction in healthy and diseased human myocardium.	MYH6 MYH7	2.49e-05	2	174	2	16088376
Pubmed	Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels.	DPP6 KCND2	2.49e-05	2	174	2	23225603
Pubmed	Complete sequence of human cardiac alpha-myosin heavy chain gene and amino acid comparison to other myosins based on structural and functional differences.	MYH6 MYH7	2.49e-05	2	174	2	1776652
Pubmed	Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.	MYH6 MYH7	2.49e-05	2	174	2	9541509
Pubmed	Dipeptidyl peptidase-like protein 6 is required for normal electrophysiological properties of cerebellar granule cells.	DPP6 KCND2	2.49e-05	2	174	2	20573902
Pubmed	Spinocerebellar Ataxia Type 1 protein Ataxin-1 is signaled to DNA damage by ataxia-telangiectasia mutated kinase.	ATXN1 ATM	2.49e-05	2	174	2	33772540
Pubmed	I SA channel complexes include four subunits each of DPP6 and Kv4.2.	DPP6 KCND2	2.49e-05	2	174	2	18364354
Pubmed	Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injury.	ATM DCLK1	2.49e-05	2	174	2	27876863
Pubmed	Protocadherin-12 cleavage is a regulated process mediated by ADAM10 protein: evidence of shedding up-regulation in pre-eclampsia.	PCDH12 ADAM10	2.49e-05	2	174	2	21402705
Pubmed	DPP6 establishes the A-type K(+) current gradient critical for the regulation of dendritic excitability in CA1 hippocampal neurons.	DPP6 KCND2	2.49e-05	2	174	2	21943606
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	STK36 MYH7 GAPVD1 KLHDC2 CAPZA1 CAPZA2 PSMD1 KLC4 RUNX3 PKD1L3 CDC42BPB LGALS3BP KMT2C SF3B3 ARHGEF7 MKLN1 EIF3F PFDN6 EPB41L2	2.57e-05	1284	174	19	17353931
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	MTA2 GAPVD1 AHCTF1 SPTAN1 NVL BAZ1B PSMD1 ATAD2 KARS1 SYNE2 ATM NXF1 EPB41L2	2.76e-05	653	174	13	22586326
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	ARHGAP32 GAPVD1 RIOK1 MIS18BP1 TRIM25 PKD1L1 CAPZA1 TAB2 MCCC1 KLC4 CARD8 RIMBP3 ODF2L CCT8 PFDN6	2.79e-05	853	174	15	28718761
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	MTA2 SEMA3F STK36 FAT4 MYH7 SPTAN1 CAPZA1 BAZ1B HES3 CARD8 KARS1 SYNE2 FKBP8 NXF1	2.89e-05	754	174	14	35906200
Pubmed	Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.	GPC1 SPTAN1 WRNIP1 ADGRB3 NVL OPHN1 ARHGEF7 STAU2 NAV3 PLCB1 PZP	3.00e-05	475	174	11	31040226
Pubmed	Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart study.	IL1RAPL1 BLID SORL1	3.39e-05	13	174	3	20838585
Pubmed	A human MAP kinase interactome.	ARHGAP32 HIVEP1 SPTAN1 PSMD1 CDC42BPB KMT2C ATXN1 ARHGEF7 NAV3 PLCB1 EPB41L2	3.69e-05	486	174	11	20936779
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	MTA2 GAPVD1 DNAJC13 RIOK1 PDE8A DIABLO CAPZA1 CAPZA2 KLC4 IFT43 CDR2L KARS1 SF3B3 GCC2 MKLN1 IQGAP3 DCLK1 FYB2 SORL1	3.78e-05	1321	174	19	27173435
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MTA2 TRIM25 SPTAN1 CAPZA1 CAPZA2 PSMD1 MCCC1 SUCLG2 ADAM10 LGALS3BP HIRA KARS1 SF3B3 SYNE2 STAU2 CCT8 ACAA2 ATM EIF3F FKBP8	3.81e-05	1440	174	20	30833792
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	TDRD15 FAT4 GAPVD1 DNAJC13 SCYL3 NBEA MCCC1 CDC42BPB GCC2 VPS13A CCT8 FKBP8 DEPDC7 EPB41L2	4.00e-05	777	174	14	35844135
Pubmed	Functional suppression of Kcnq1 leads to early sodium channel remodelling and cardiac conduction system dysmorphogenesis.	MYH6 MYH7 KCND2	4.30e-05	14	174	3	23542581
Pubmed	Integrative characterization of germ cell-specific genes from mouse spermatocyte UniGene library.	RIMBP3 RIMBP3C RIMBP3B	4.30e-05	14	174	3	17662146
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	RNF169 GAPVD1 SPAST CAPZA2 PSMD1 TAB2 STK10 KMT2C NPTN GARIN3 CSNK1G2 RIMBP3C QKI	4.77e-05	689	174	13	36543142
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	MTA2 RNASEH2A AHCTF1 PIK3R3 ZMYND8 WRNIP1 BAZ1B CHD9 EZH1 ABCA8 LGALS3BP SF3B3 HMCN2 ATXN1 FKBP8 AFF4 SORL1	4.91e-05	1116	174	17	31753913
Pubmed	Methyltransferase-like 21e inhibits 26S proteasome activity to facilitate hypertrophy of type IIb myofibers.	RIOK1 CAPZA1 CAPZA2 PSMD1 KARS1 SF3B3 ACAA2 EIF3F	5.19e-05	259	174	8	31162944
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	MTA2 GAPVD1 AHCTF1 SPTAN1 CAPZA1 CAPZA2 WRNIP1 CYFIP2 SF3B3 CCT8 PFDN6	5.31e-05	506	174	11	30890647
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	TRIM25 ZMYND8 CAPZA2 BAZ1B SUCLG2 KARS1 STAU2 CCT8 ACAA2 EIF3F IQGAP3 NXF1 EPB41L2	5.93e-05	704	174	13	29955894
Pubmed	In vitro nuclear interactome of the HIV-1 Tat protein.	MTA2 AHCTF1 BAZ1B ORC4 SF3B3 STAU2 EIF3F	6.02e-05	195	174	7	19454010
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	STK36 ARHGAP32 TSHZ3 TRIM25 PIK3R3 ZMYND8 KMT2E STK10 XIRP2 ATM	6.70e-05	430	174	10	35044719
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	SPTAN1 ADGRB3 PSMD1 NBEA GRIN2A KCND2 ARHGEF7 PLCB1 DCLK1	6.82e-05	347	174	9	17114649
Pubmed	Vertebrates have conserved capping protein alpha isoforms with specific expression patterns.	CAPZA1 CAPZA2	7.44e-05	3	174	2	9331217
Pubmed	Endogenous retinoic acid signaling colocalizes with advanced expression of the adult smooth muscle myosin heavy chain isoform during development of the ductus arteriosus.	MYH6 MYH7	7.44e-05	3	174	2	8620598
Pubmed	Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy.	MYH6 MYH7	7.44e-05	3	174	2	20923879
Pubmed	Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro.	MYH6 MYH7	7.44e-05	3	174	2	1694848
Pubmed	Macrophages Are a Potent Source of Streptococcus-Induced IFN-β.	TLR7 IFNB1	7.44e-05	3	174	2	31732532
Pubmed	Discordant on/off switching of gene expression in myocytes during cardiac hypertrophy in vivo.	MYH6 MYH7	7.44e-05	3	174	2	18755891
Pubmed	Crystal structure of the Rab9A-RUTBC2 RBD complex reveals the molecular basis for the binding specificity of Rab9A with RUTBC2.	RAB9B RAB9A	7.44e-05	3	174	2	25220469
Pubmed	Conotruncal anomalies in the trisomy 16 mouse: an immunohistochemical analysis with emphasis on the involvement of the neural crest.	MYH6 MYH7	7.44e-05	3	174	2	11066038
Pubmed	RNA Sensing by Gut Piezo1 Is Essential for Systemic Serotonin Synthesis.	PIEZO1 TLR7	7.44e-05	3	174	2	32640190
Pubmed	DPP6 regulation of dendritic morphogenesis impacts hippocampal synaptic development.	DPP6 KCND2	7.44e-05	3	174	2	23912628
Pubmed	Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy.	MYH6 MYH7	7.44e-05	3	174	2	18362229
Pubmed	Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study.	MYH6 MYH7	7.44e-05	3	174	2	1939265
Pubmed	Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop.	TLR7 IFNB1	7.44e-05	3	174	2	19587008
Pubmed	Solution NMR structure of S100B bound to the high-affinity target peptide TRTK-12.	CAPZA1 CAPZA2	7.44e-05	3	174	2	12470955
Pubmed	Shear stress activates ADAM10 sheddase to regulate Notch1 via the Piezo1 force sensor in endothelial cells.	PIEZO1 ADAM10	7.44e-05	3	174	2	32484440
Pubmed	Capping protein regulates endosomal trafficking by controlling F-actin density around endocytic vesicles and recruiting RAB5 effectors.	CAPZA1 CAPZA2	7.44e-05	3	174	2	34796874
Pubmed	Mutation in myosin heavy chain 6 causes atrial septal defect.	MYH6 MYH7	7.44e-05	3	174	2	15735645
Cytoband	13q13	NBEA DCLK1	1.42e-04	5	174	2	13q13
GeneFamily	AAA ATPases	SPAST WRNIP1 NVL ATAD2 ORC4	2.33e-05	53	117	5	413
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	GAPVD1 DNAJC13 HIVEP1 SPAST PDE8A AHCTF1 DDR2 ZMYND8 NVL BAZ1B CHD9 TAB2 ADAM10 HIRA STK10 ATXN1 ARHGEF7 GCC2 SYNE2 STAU2 VPS13A MKLN1 NAV3 QKI	2.46e-09	856	173	24	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	GAPVD1 DNAJC13 HIVEP1 PDE8A ZMYND8 NVL CHD9 TAB2 ADAM10 HIRA ARHGEF7 STAU2 VPS13A MKLN1 QKI	5.26e-07	466	173	15	M13522
Coexpression	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	GPC1 KRT4 ARHGAP32 SAMD9 TRIM25 ZMYND8 BAZ1B CHD9 IRF6 KLC4 ATAD2 STK10 KMT2C NPTN FAT2 ATXN1 SYNE2 DEPDC7 QKI	3.35e-06	843	173	19	M2356
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HRGL2A	GPC1 DPP6 VEPH1 ADGRB3 NPAS3 NBEA OPHN1 LGALS3BP FAT2 RAB9A LRRIQ1 ATXN1 NRK QKI DCLK1	1.14e-05	600	173	15	M39055
Coexpression	BYSTROEM_CORRELATED_WITH_IL5_DN	NVL BAZ1B ADAM10 SLFN12L SORL1	4.81e-05	60	173	5	M1401
Coexpression	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN	MYH7 SAMD9 TRIM25 PIK3R3 LGALS3BP GTF2B KARS1 HMCN2	4.82e-05	195	173	8	M4292
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	GAPVD1 MIS18BP1 SAMD9 RNF19A TTC39C PIEZO1 SPTAN1 CAPZA1 BAZ1B TAB2 KMT2E RUNX3 CARD8 CYFIP2 STK10 KMT2C SLAMF6 SF3B3 ATXN1 CSNK1G2 ATM EIF3F QKI SORL1	4.85e-05	1492	173	24	M40023
Coexpression	GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN	GPC1 DNAJC13 RNF19A BAZ1B RYR1 CSNK1G2 TAC1 EPB41L2	5.56e-05	199	173	8	M3912
Coexpression	GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN	RNF19A ATP8A2 RUNX3 RYR1 OPHN1 LGALS3BP GALNT9 SORL1	5.56e-05	199	173	8	M4348
Coexpression	GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP	TRIM25 RNF19A TAB2 EZH1 LGALS3BP SLAMF6 EIF3F AFF4	5.76e-05	200	173	8	M6253
ToppCell	COVID-19-kidney-NK\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SAMD9 RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 ATM PZP SORL1	2.49e-09	181	173	10	8906ee8a7a1616dfe8c3b5c73988416641213629
ToppCell	Control-T_cells-NK_cells\|Control / group, cell type (main and fine annotations)	RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 PLCB1 ATM PZP SORL1	3.08e-09	185	173	10	755c0998c729f462399f1d5e88adf4bfae31be30
ToppCell	Control-T_cells\|Control / group, cell type (main and fine annotations)	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 SYNE2 ATM SORL1	3.42e-09	187	173	10	f4e8e0eba58da89b56587667555a5d4754e108c7
ToppCell	COVID-19-T_cells-NK_cells\|COVID-19 / group, cell type (main and fine annotations)	RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 SYNE2 PLCB1 PZP SORL1	3.78e-09	189	173	10	b699152dfbb8cd8ed724e1e5a51838f29b681b62
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	TRHDE DDR2 ADGRB3 CHD9 ABCA8 OPHN1 PLCB1 DCLK1 BICC1 EPB41L2	4.19e-09	191	173	10	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 PLCB1 ATM PZP SORL1	4.63e-09	193	173	10	1cb666375bc4e1b11a146d20896c9b5ae6fd0887
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GLT8D2 FAT4 DDR2 ABCA8 HMCN2 NRK NAV3 DCLK1 BICC1 EPB41L2	4.86e-09	194	173	10	439d3f17c1f4736122b330e98add9292c7036a8e
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	DDR2 ADGRB3 CHD9 ABCA8 OPHN1 HMCN2 KCND2 PLCB1 DCLK1 BICC1	5.11e-09	195	173	10	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	COVID_non-vent-Lymphocytic-ILC\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SAMD9 RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 SYNE2 ATM SORL1	6.21e-09	199	173	10	df4f7d5be099e3e6054f3b812ccf70251664e4c0
ToppCell	COVID_non-vent-Lymphocytic-ILC-NK_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SAMD9 RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 SYNE2 ATM SORL1	6.21e-09	199	173	10	ed35d747f11f6ea6a5cb7061057f0a98d9e0db99
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE FAT4 DDR2 ADGRB3 ABCA8 KCND2 NAV3 DCLK1 BICC1 EPB41L2	6.51e-09	200	173	10	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Adult-Immune-natural_killer_cell-D175\|Adult / Lineage, Cell type, age group and donor	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 SYNE2 PLCB1	3.79e-08	180	173	9	fc59e28f39e7d4fb1bcc7205202cf39224b70d7b
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE GLT8D2 DDR2 NPAS3 GRID1 ABCA8 PXDNL NAV3 BICC1	3.79e-08	180	173	9	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	RNF19A TTC39C SPTAN1 ATXN1 SYNE2 VPS13A MKLN1 PLCB1 ATM	3.97e-08	181	173	9	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	Control-T_cells-CD8+_T_cells\|Control / group, cell type (main and fine annotations)	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 PLCB1 ATM PZP	4.79e-08	185	173	9	02ab64c0166c0646d1d4c6ed110ef0b75a1096d0
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	DDR2 ADGRB3 CHD9 ABCA8 HMCN2 KCND2 PLCB1 DCLK1 BICC1	5.26e-08	187	173	9	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TTC39C SPTAN1 SLFN12L ODF2L CD226 SYNE2 ATM PZP SORL1	5.76e-08	189	173	9	5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	DDR2 ADGRB3 NPAS3 CHD9 ABCA8 OPHN1 NRK DCLK1 BICC1	6.03e-08	190	173	9	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	Adult-Immune-natural_killer_cell\|Adult / Lineage, Cell type, age group and donor	RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 SYNE2 PLCB1 SORL1	6.31e-08	191	173	9	758ec27e47d7662a5175305e98a1506c6859dbf7
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 PLCB1 ATM SORL1	6.31e-08	191	173	9	9b8b64a36e27a2523b8730c7922fd7ad865a021e
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	DDR2 ADGRB3 NPAS3 CHD9 ABCA8 NRK PLCB1 DCLK1 BICC1	6.31e-08	191	173	9	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	Children_(3_yrs)-Immune-natural_killer_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 PLCB1 ATM PZP	6.31e-08	191	173	9	6345c1aa0fd2f9f2154a44f9393bf7c72bb1f44e
ToppCell	COVID-19-T_cells\|COVID-19 / group, cell type (main and fine annotations)	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 SYNE2 SORL1	6.31e-08	191	173	9	7f64add931b64b8d35836fa6bee9ebab593844d3
ToppCell	Immune-natural_killer_cell\|World / Lineage, Cell type, age group and donor	RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 PLCB1 ATM SORL1	6.59e-08	192	173	9	68121a6ef4115a93d87aad8802ef9b27d793d8c0
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	GLT8D2 FAT4 DDR2 ABCA8 NRK NAV3 DCLK1 BICC1 EPB41L2	6.59e-08	192	173	9	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	DDR2 ADGRB3 NPAS3 CHD9 ABCA8 OPHN1 PLCB1 DCLK1 BICC1	6.89e-08	193	173	9	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RUNX3 CARD8 SLFN12L SLAMF6 ATXN1 GCC2 SYNE2 ATM PZP	6.89e-08	193	173	9	a594f89a18273797506287d9e22f72abe53e4920
ToppCell	COVID-19-kidney-T-cells-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 ATM SORL1	6.89e-08	193	173	9	5b84fa640cf30dea55fde53b810f850ff946d253
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 SYNE2 PZP	6.89e-08	193	173	9	b9769b45125d2244afe53f9f71c92c04ddccf980
ToppCell	Immune-T_lymphocyte\|World / Lineage, Cell type, age group and donor	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 ATM PZP	7.21e-08	194	173	9	f47fa18c87b35a3960557f8169ff7830dd6ecb80
ToppCell	facs-Brain_Myeloid-Hippocampus\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT4 CHD9 ADAM10 OPHN1 NPTN NAV3 MED12L QKI EPB41L2	7.53e-08	195	173	9	a1478021a3ed0e779716393124ca2a7770c433b7
ToppCell	RV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ARHGAP32 DDR2 ADGRB3 CHD9 ABCA8 PLCB1 DCLK1 BICC1 EPB41L2	7.53e-08	195	173	9	ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48
ToppCell	COVID_non-vent-Lymphocytic\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	SPTAN1 KMT2E RUNX3 CYFIP2 SLFN12L SLAMF6 GCC2 SYNE2 ATM	8.22e-08	197	173	9	c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	KMT2E RUNX3 CYFIP2 STK10 SLFN12L ODF2L SLAMF6 SYNE2 ATM	8.22e-08	197	173	9	836061acd7f0d5de89b16f52ec679bdf09eac9db
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGAP32 ATP8A2 SPTAN1 ADGRB3 NBEA GRIN2A NPTN PLCB1 DCLK1	8.58e-08	198	173	9	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	mild-CD4+_Tcm\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF19A TTC39C SPTAN1 TAB2 SLFN12L ODF2L CD226 GCC2 SYNE2	8.96e-08	199	173	9	06c8a0e39f7a33736548f04a5e2263334c8541cf
ToppCell	10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	SEMA3F GLT8D2 FAT4 DDR2 ABCA8 NRK TAC1 DCLK1 BICC1	9.35e-08	200	173	9	fee22a6a6c7b93af204b5b56f2c34f1411500e18
ToppCell	Bronchial-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TRHDE DDR2 ADGRB3 ABCA8 NAV3 LMOD1 DCLK1 BICC1 EPB41L2	9.35e-08	200	173	9	389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 RUNX3 SLFN12L ODF2L CD226 SYNE2 PLCB1 ATM PZP	9.35e-08	200	173	9	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 PLCB1 PZP	9.35e-08	200	173	9	c6c2b39359c65c9444987d02d1c899dff2ad1366
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 PLCB1 PZP	9.35e-08	200	173	9	02c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RUNX3 ADAM10 CYFIP2 SLFN12L XIRP2 CD226 SYNE2 ATM	2.10e-07	159	173	8	bf8ff9251bcb64b2b9d6dd93461aec97659686ec
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CAPN12 RNF19A RUNX3 ATAD2 STK10 SLFN12L FAT2 ATXN1	3.35e-07	169	173	8	8caf7996796a2e2716e3855de855c903d6126bf2
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DDR2 ABCA8 KCND2 BLID NAV3 LMOD1 DCLK1 EPB41L2	3.66e-07	171	173	8	5d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 DDR2 ABCA8 KCND2 NAV3 LMOD1 DCLK1 EPB41L2	4.37e-07	175	173	8	795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE DDR2 NPAS3 GRID1 ABCA8 PXDNL NAV3 BICC1	5.41e-07	180	173	8	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	TTC39C SPTAN1 ODF2L ATXN1 CD226 SYNE2 PZP SORL1	5.41e-07	180	173	8	d9dae9db8e17f6990032ee6cfa8393fae4768ca5
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TRHDE GLT8D2 DDR2 NPAS3 GRID1 ABCA8 PXDNL BICC1	5.64e-07	181	173	8	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE STK36 FAT4 GRID1 ODAD2 XIRP2 NRK NAV3	6.39e-07	184	173	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	FAT4 TLR7 ABCA8 IL1RAPL1 NRK NAV3 QKI EPB41L2	6.39e-07	184	173	8	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DDR2 GRIN2A ABCA8 KCND2 NAV3 LMOD1 DCLK1 EPB41L2	6.39e-07	184	173	8	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE STK36 FAT4 GRID1 ODAD2 XIRP2 NRK NAV3	6.39e-07	184	173	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRHDE STK36 FAT4 GRID1 ODAD2 XIRP2 NRK NAV3	6.39e-07	184	173	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DDR2 ADGRB3 ABCA8 HMCN2 PXDNL PLCB1 DCLK1 BICC1	6.65e-07	185	173	8	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	TRHDE DPP6 NRK SYNE2 MKLN1 PLCB1 DIAPH3 BICC1	7.21e-07	187	173	8	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	GLT8D2 DDR2 ABCA8 HMCN2 NAV3 LMOD1 DCLK1 EPB41L2	7.51e-07	188	173	8	ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell	COVID-19-Heart-Fib_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DDR2 ADGRB3 ABCA8 IL1RAPL1 HMCN2 PLCB1 DCLK1 BICC1	7.51e-07	188	173	8	fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCell	ILEUM-inflamed-(1)_Cytotoxic_CD8_Trm\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	RNF19A TRA TTC39C KMT2E RUNX3 ODF2L CD226 SYNE2	7.51e-07	188	173	8	d26894d1066a70e4b32ae41fff1c4718f2591ba9
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH6 MYH7 MYOM1 ABCA8 IL1RAPL1 XIRP2 PXDNL PLCB1	8.13e-07	190	173	8	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	Control-T_cells-CD4+_T_cells\|Control / group, cell type (main and fine annotations)	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 SYNE2	8.13e-07	190	173	8	0733be5e54fe15d6d6ea51c154a95258e83f1b92
ToppCell	COVID-19-kidney-NK\|kidney / Disease (COVID-19 only), tissue and cell type	SAMD9 RUNX3 STK10 SLFN12L SLAMF6 CD226 ATM PZP	8.13e-07	190	173	8	e3ca3c9fb9e27670a5dd128dd6564ff98a57159e
ToppCell	COVID-19-lung-CD8+_T_cells\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TTC39C RUNX3 STK10 SLFN12L SLAMF6 CD226 PZP SORL1	8.46e-07	191	173	8	543f8ae07cc2e6950c888115a5ca9445e3c0f618
ToppCell	COVID-19-T_cells-CD4+_T_cells\|COVID-19 / group, cell type (main and fine annotations)	TTC39C RUNX3 CYFIP2 SLFN12L SLAMF6 CD226 SYNE2 SORL1	8.46e-07	191	173	8	0646cca78e24aeb6baa9934d3c439b797c567997
ToppCell	Fetal_29-31_weeks-Immune-T_lymphocyte-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 ATM PZP	8.80e-07	192	173	8	92f141d5ac462f652f405efa73ac6ef751f40ea3
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	DDR2 ABCA8 HMCN2 NRK NAV3 DCLK1 BICC1 EPB41L2	8.80e-07	192	173	8	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	DDR2 ADGRB3 ABCA8 OPHN1 PLCB1 DCLK1 BICC1 EPB41L2	8.80e-07	192	173	8	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHD9 TLR7 ADAM10 OPHN1 NPTN NAV3 MED12L QKI	9.15e-07	193	173	8	9c16032bc03df8760ae199e8f19fdafa4c3f1827
ToppCell	LA\|World / Chamber and Cluster_Paper	DDR2 ABCA8 HMCN2 KCND2 PLCB1 LMOD1 DCLK1 BICC1	9.15e-07	193	173	8	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	Adult-Immune-T_lymphocyte\|Adult / Lineage, Cell type, age group and donor	TTC39C RUNX3 CYFIP2 SLFN12L SLAMF6 CD226 SYNE2 PLCB1	9.15e-07	193	173	8	26df0c4c8a2355dd5503fadd07e368eb9a2bf06a
ToppCell	COVID-19-lung-CD8+_T_cells\|lung / Disease (COVID-19 only), tissue and cell type	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 PZP	9.15e-07	193	173	8	780e23e2705fc5c1b70e37568b79731ced5038bd
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	RNF19A KMT2E RUNX3 CYFIP2 SLFN12L CD226 SYNE2 SORL1	9.15e-07	193	173	8	00349d176fb6a46cbcc99c41d975651b6e9aaad4
ToppCell	COVID-19_Mild-PLT_4\|World / Disease Group and Platelet Clusters	MIS18BP1 AHCTF1 ZMYND8 CHD9 GTF2B RAB9A XIRP2 GCC2	9.15e-07	193	173	8	98a52523aa1efd5d14a2878ed106828a80a33aa2
ToppCell	COVID-19-lung-NK/NKT\|COVID-19 / Disease (COVID-19 only), tissue and cell type	RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 ATM SORL1	9.15e-07	193	173	8	c24b44fcc92fff42ebba6f1aff91c7aaea179e56
ToppCell	facs-Skin-Telogen-3m-Epithelial\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MTA2 IL13RA1 AHCTF1 IRF6 NPTN SYNE2 CCT8 AFF4	9.52e-07	194	173	8	4d7fc4d0a55abb3b645116d13a983bbedc55f70c
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 SYNE2	9.52e-07	194	173	8	3d6f2d190dd50804afea299957cc44c2bb756134
ToppCell	facs-Skin-Telogen-3m\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MTA2 IL13RA1 AHCTF1 IRF6 NPTN SYNE2 CCT8 AFF4	9.52e-07	194	173	8	ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b
ToppCell	facs-Skin-Telogen\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MTA2 IL13RA1 AHCTF1 IRF6 NPTN SYNE2 CCT8 AFF4	9.52e-07	194	173	8	bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	DDR2 ADGRB3 CHD9 ABCA8 OPHN1 PLCB1 DCLK1 BICC1	9.52e-07	194	173	8	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	Adult-Immune-T_lymphocyte-D231\|Adult / Lineage, Cell type, age group and donor	TTC39C RUNX3 CYFIP2 SLFN12L SLAMF6 CD226 SYNE2 PLCB1	9.52e-07	194	173	8	5c1dca33f382f37a7deb23e573578343c3b54986
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DDR2 GRIN2A ABCA8 KCND2 NAV3 LMOD1 DCLK1 EPB41L2	9.89e-07	195	173	8	3c3703f092b6fc1b7333426fb5e2823bfb74bb57
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	RNF19A RUNX3 CYFIP2 SLFN12L SLAMF6 CD226 SYNE2 SORL1	9.89e-07	195	173	8	36c784709ee32174e05b457500339c3b8eee3244
ToppCell	COVID-19-lung-NK/NKT\|lung / Disease (COVID-19 only), tissue and cell type	RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 ATM SORL1	9.89e-07	195	173	8	3ab941a369e3815f338890b116dc77aefa054098
ToppCell	RA-02._Fibroblast_II\|RA / Chamber and Cluster_Paper	DDR2 ADGRB3 CHD9 ABCA8 OPHN1 PLCB1 DCLK1 BICC1	9.89e-07	195	173	8	6a02ebbeb3199447ddce64d92d8809436e040eba
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGAP32 TTC39C GRIN2A VPS13A NAV3 PLCB1 DCLK1 SORL1	9.89e-07	195	173	8	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RNF19A KMT2C SLFN12L GCC2 SYNE2 VPS13A GARIN1B ATM	1.07e-06	197	173	8	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RUNX3 CYFIP2 SLFN12L ODF2L CD226 GCC2 SYNE2 PZP	1.07e-06	197	173	8	59b1fb93a39dcf8c994d2b7dc2906dae74c57527
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ATP8A2 ADGRB3 NBEA GRIN2A NPTN KCND2 PLCB1 DCLK1	1.11e-06	198	173	8	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RUNX3 CYFIP2 STK10 SLFN12L CD226 SYNE2 PLCB1 PZP	1.11e-06	198	173	8	9ce9b3721fb8a154667211c29e60133412134c76
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD3\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RUNX3 CYFIP2 STK10 SLFN12L CD226 SYNE2 PLCB1 PZP	1.11e-06	198	173	8	3c23fb8a84d4e4a20f7fa60055c7b37fc45a29d5
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FAT4 TSHZ3 DDR2 ADGRB3 ABCA8 DCLK1 BICC1 EPB41L2	1.11e-06	198	173	8	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	FAT4 DDR2 ADGRB3 ABCA8 NAV3 DCLK1 BICC1 EPB41L2	1.15e-06	199	173	8	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD3\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RUNX3 CYFIP2 SLFN12L SLAMF6 CD226 SYNE2 TRAV38-2DV8 TRAV14DV4	1.15e-06	199	173	8	eb30711ab34510429b644498ecfab4ec3cb61cbc
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 ADGRB3 NBEA OPHN1 KMT2C ATXN1 MKLN1 UBR3	1.15e-06	199	173	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD3-NKT\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RUNX3 CYFIP2 SLFN12L SLAMF6 CD226 SYNE2 TRAV38-2DV8 TRAV14DV4	1.15e-06	199	173	8	40f9f771004850be477ee491a7a74c74b84074ab
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 PLCB1 ATM PZP	1.15e-06	199	173	8	eb188b0b457136b6ee485d3b3052baa30d9c0002
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RNF19A TTC39C RUNX3 STK10 SLFN12L SLAMF6 PZP TRAV14DV4	1.20e-06	200	173	8	7a9c3f51d4a8fda5f1b7e0be6fcf9c1c92fffe99
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T\|COVID-19_Mild / Disease, condition lineage and cell class	RUNX3 CYFIP2 SLFN12L ODF2L CD226 SYNE2 ATM PZP	1.20e-06	200	173	8	6560753d3df2f87860b52052d4881aa45410f666
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SAMD9 RNF19A RUNX3 SLFN12L CD226 SYNE2 ATM PZP	1.20e-06	200	173	8	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TTC39C RUNX3 CYFIP2 STK10 SLFN12L SLAMF6 CD226 PLCB1	1.20e-06	200	173	8	be9a43acc2f926b9433ab3f018b911b03896a924
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RUNX3 STK10 SLFN12L SLAMF6 CD226 PLCB1 ATM SORL1	1.20e-06	200	173	8	7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	ZMYND8 IRF6 EZH1 ADAM10 SF3B3 SYNE2 PLCB1 ATM QKI SORL1	1.46e-06	191	166	10	4168_DN
Disease	Colorectal Carcinoma	STARD8 ZNF560 RBP3 GRID1 GRIN2A ABCA8 KMT2C GTF2B SIGLEC7 ABCB10 CD226 VPS13A PZP QKI DCLK1 SORL1	1.28e-06	702	158	16	C0009402
Disease	smoking status measurement	TRHDE SEMA3F DPP6 GAPVD1 SAMD9 CAPZA2 ADGRB3 NPAS3 GRID1 GRIN2A CDC42BPB KCND2 PXDNL INSC MED12L TAC1 DIAPH3 FKBP8 SORL1	1.54e-05	1160	158	19	EFO_0006527
Disease	skin microbiome measurement	MTSS1 ADGRB3 NPAS3 CARD8	5.62e-05	39	158	4	EFO_0801228
Disease	distal arthrogryposis (implicated_via_orthology)	MYH6 MYH7 ECEL1	6.54e-05	15	158	3	DOID:0050646 (implicated_via_orthology)
Disease	nasopharynx carcinoma (is_marker_for)	DDR2 GRIN2A KMT2C ATM	8.30e-05	43	158	4	DOID:9261 (is_marker_for)
Disease	alcohol consumption measurement	CAPN12 ANKK1 SEMA3F DPP6 DDR2 ADGRB3 NPAS3 GRID1 NBEA SUCLG2 PKD1L3 ATXN1 KCND2 GALNT9 PLCB1 DCLK1 AFF4 SORL1	1.25e-04	1242	158	18	EFO_0007878
Disease	Intellectual Disability	RNASEH2A ATP8A2 NBEA PCDH12 KMT2E KMT2C KARS1 MED12L EIF3F QKI	1.57e-04	447	158	10	C3714756
Disease	cerebellum white matter volume change measurement, age at assessment	TRHDE ADGRB3 ABCA8	1.61e-04	20	158	3	EFO_0008007, EFO_0021498
Disease	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	MYH6 MYH7	1.70e-04	4	158	2	C3495498
Disease	Hypertrophic cardiomyopathy 1	MYH6 MYH7	1.70e-04	4	158	2	cv:C3495498
Disease	Caveolinopathy	MYH6 MYH7	1.70e-04	4	158	2	cv:C5679790
Disease	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH6 MYH7	1.70e-04	4	158	2	192600
Disease	Infiltrating duct carcinoma of female breast	ANKK1 CDC42BPB NRK	1.87e-04	21	158	3	C3165106
Disease	vascular cell adhesion molecule-1 measurement	GLT8D2 ABCA8	2.82e-04	5	158	2	EFO_0010057
Disease	protachykinin-1 measurement	PLCB1 TAC1	4.21e-04	6	158	2	EFO_0801934
Disease	Congenital myopathy with fiber type disproportion	MYH7 RYR1	4.21e-04	6	158	2	cv:C0546264
Disease	Barrett's esophagus	DPP6 GRID1 HMCN2	4.47e-04	28	158	3	EFO_0000280
Disease	T-cell immunoglobulin and mucin domain 1 measurement	ABCA8 CYFIP2	5.88e-04	7	158	2	EFO_0010812
Disease	Idiopathic hypertrophic subaortic stenosis	MYH6 MYH7	5.88e-04	7	158	2	C0700053
Disease	hepatitis C virus infection, cirrhosis of liver	GLT8D2 PKD1L1	5.88e-04	7	158	2	EFO_0001422, EFO_0003047
Disease	Obstructive asymmetric septal hypertrophy	MYH6 MYH7	5.88e-04	7	158	2	C0597124
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	MYH7 SYNE2	5.88e-04	7	158	2	C0751337
Disease	Large cell carcinoma of lung	ANKK1 DDR2 CDC42BPB	6.67e-04	32	158	3	C0345958
Disease	neuropsychological test	TRHDE FAT4 TSHZ3 CAPZA2 SLAMF6 PLCB1	6.95e-04	197	158	6	EFO_0003926
Disease	migraine disorder	ZMYND8 BAZ1B NBEA IFT43 STK10 INSC BICC1 EPB41L2	7.09e-04	357	158	8	MONDO_0005277
Disease	carnitine measurement	MCCC1 SUCLG2 NRK PLCB1	7.52e-04	76	158	4	EFO_0010469
Disease	Colorectal Neoplasms	STARD8 GRID1 GRIN2A ABCA8 ABCB10 CD226 DCLK1	7.61e-04	277	158	7	C0009404
Disease	cleft lip	ATP8A2 ADGRB3 IRF6 GRIN2A ATXN1 BICC1 FYB2	8.81e-04	284	158	7	EFO_0003959
Disease	Vertigo	DPP6 PSMD1 KCND2 MED12L DIAPH3	9.33e-04	139	158	5	HP_0002321
Disease	Cardiomyopathy, Hypertrophic, Familial	MYH6 MYH7	1.00e-03	9	158	2	C0949658
Disease	Autism Spectrum Disorders	DPP6 TSHZ3 IL1RAPL1 IQGAP3	1.14e-03	85	158	4	C1510586
Disease	Seizures	NBEA KMT2E IFNB1 KARS1 MED12L EIF3F	1.17e-03	218	158	6	C0036572
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	DNHD1 RYR1 SYNE2 NAV3 ATM	1.23e-03	148	158	5	C0279702
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH6 MYH7	1.25e-03	10	158	2	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH6 MYH7	1.25e-03	10	158	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH6 MYH7	1.25e-03	10	158	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH6 MYH7	1.25e-03	10	158	2	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH6 MYH7	1.25e-03	10	158	2	DOID:0080719 (implicated_via_orthology)
Disease	Muscular dystrophy, limb-girdle, autosomal dominant	MYH6 MYH7	1.25e-03	10	158	2	cv:C5675009
Disease	inclusion body myositis (implicated_via_orthology)	MYH6 MYH7	1.25e-03	10	158	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH6 MYH7	1.25e-03	10	158	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH6 MYH7	1.25e-03	10	158	2	DOID:0080326 (implicated_via_orthology)
Disease	Paroxysmal atrial fibrillation	MYH6 MYH7 ATXN1 SYNE2 SORL1	1.56e-03	156	158	5	C0235480
Disease	familial atrial fibrillation	MYH6 MYH7 ATXN1 SYNE2 SORL1	1.56e-03	156	158	5	C3468561
Disease	Persistent atrial fibrillation	MYH6 MYH7 ATXN1 SYNE2 SORL1	1.56e-03	156	158	5	C2585653
Disease	hereditary spastic paraplegia (implicated_via_orthology)	CAPN12 SPAST DDHD2	1.59e-03	43	158	3	DOID:2476 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	SPAST KMT2E CDC42BPB KMT2C	1.60e-03	93	158	4	C1535926
Disease	cognitive impairment measurement	ADGRB3 PXDNL NAV3	1.70e-03	44	158	3	EFO_0007998
Disease	Squamous cell carcinoma of esophagus	FAT4 CAPZA1 KMT2C FAT2	1.73e-03	95	158	4	C0279626
Disease	Atrial Fibrillation	MYH6 MYH7 ATXN1 SYNE2 SORL1	1.74e-03	160	158	5	C0004238
Disease	distal myopathy (implicated_via_orthology)	MYH6 MYH7	1.82e-03	12	158	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH6 MYH7	1.82e-03	12	158	2	DOID:2106 (implicated_via_orthology)
Disease	alcohol and nicotine codependence	HIVEP1 KCND2	2.14e-03	13	158	2	EFO_0004776
Disease	Autosomal Dominant Myotubular Myopathy	MYH7 RYR1	2.14e-03	13	158	2	C3661489
Disease	Centronuclear myopathy	MYH7 RYR1	2.14e-03	13	158	2	C0175709
Disease	X-linked centronuclear myopathy	MYH7 RYR1	2.14e-03	13	158	2	C0410203
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH6 MYH7	2.14e-03	13	158	2	DOID:397 (implicated_via_orthology)
Disease	fatty acid measurement, fetal genotype effect measurement, breast milk measurement	ATP8A2 DIAPH3	2.14e-03	13	158	2	EFO_0005110, EFO_0007959, EFO_0009092
Disease	Myopathy, Centronuclear, 1	MYH7 RYR1	2.14e-03	13	158	2	C4551952
Disease	Congenital Structural Myopathy	MYH7 RYR1	2.14e-03	13	158	2	C0752282
Disease	Cardiomyopathy, Dilated	MYH6 MYH7 ATM	2.18e-03	48	158	3	C0007193
Disease	developmental disorder of mental health (implicated_via_orthology)	CAPZA1 CAPZA2 GRIN2A	2.32e-03	49	158	3	DOID:0060037 (implicated_via_orthology)
Disease	Cardiomyopathy, Familial Idiopathic	MYH6 MYH7 ATM	2.46e-03	50	158	3	C1449563
Disease	Myopathy, Centronuclear, Autosomal Dominant	MYH7 RYR1	2.49e-03	14	158	2	C1834558
Disease	Tubular Aggregate Myopathy	MYH7 RYR1	2.49e-03	14	158	2	C0410207
Disease	fatty acid measurement, breast milk measurement, parental genotype effect measurement	ATP8A2 DIAPH3	2.49e-03	14	158	2	EFO_0005110, EFO_0005939, EFO_0009092
Disease	mean corpuscular hemoglobin concentration	DNAJC13 SAMD9 PIEZO1 PIK3R3 EZH1 SUCLG2 ATXN1 CD226 GALNT9 VPS13A PLCB1 EIF3F FKBP8 EPB41L2	2.55e-03	1105	158	14	EFO_0004528
Disease	platelet component distribution width	CAPN12 GAPVD1 STARD8 MTSS1 ZMYND8 CAPZA2 CD226 GCC2 PLCB1 DEPDC7 QKI	2.58e-03	755	158	11	EFO_0007984
Disease	response to statin, LDL cholesterol change measurement	TDRD15 EPB41L2	2.86e-03	15	158	2	EFO_0007804, GO_0036273
Disease	Autosomal Recessive Centronuclear Myopathy	MYH7 RYR1	2.86e-03	15	158	2	C3645536
Disease	syndromic intellectual disability (implicated_via_orthology)	ZMYND8 OPHN1	3.25e-03	16	158	2	DOID:0050888 (implicated_via_orthology)
Disease	level of Phosphatidylethanolamine (16:0_20:4) in blood serum	ADAM10 FAM81A	3.25e-03	16	158	2	OBA_2045137
Disease	Abnormal behavior	MED12L EIF3F	3.25e-03	16	158	2	C0233514
Disease	Narcolepsy-Cataplexy Syndrome	TRA TAC1	3.25e-03	16	158	2	C0751362
Disease	mean platelet volume	SEMA3F ARHGAP32 STARD8 ZMYND8 CAPZA1 CAPZA2 CHD9 CDC42BPB CD226 GCC2 GALNT9 SYNE2 PLCB1	3.43e-03	1020	158	13	EFO_0004584
Disease	Abnormality of refraction	ARHGAP32 TSHZ3 DNAJC13 PKD1L1 NBEA GRIN2A ECEL1 PZP QKI BICC1	3.49e-03	673	158	10	HP_0000539
Disease	Hypertrophic Cardiomyopathy	MYH6 MYH7 MYOM1	3.57e-03	57	158	3	C0007194
Disease	SLAM family member 7 measurement	DDR2 RUNX3	3.68e-03	17	158	2	EFO_0008287
Disease	Narcolepsy	TRA TAC1	3.68e-03	17	158	2	C0027404
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	TRHDE TSHZ3 GAPVD1 HIVEP1 NPAS3 NBEA GRIN2A KCND2 TAC1 FKBP8 SORL1	4.03e-03	801	158	11	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	response to platinum based chemotherapy	ODAD2 TAC1	4.12e-03	18	158	2	EFO_0004647
Disease	Congenital Fiber Type Disproportion	MYH7 RYR1	4.12e-03	18	158	2	C0546264
Disease	abdominal fat cell number	TRHDE DNAJC13 ADAM10 XIRP2 DIAPH3	4.35e-03	198	158	5	EFO_0021534
Disease	cognitive function measurement	HIVEP1 SAMD9 PIEZO1 MTSS1 GRID1 NBEA GRIN2A KMT2E PKD1L3 ABCA8 IL1RAPL1 ATXN1 MED12L PLCB1 DIAPH3 DCLK1	4.46e-03	1434	158	16	EFO_0008354
Disease	HETE measurement	DPP6 PIEZO1 CD226	4.52e-03	62	158	3	EFO_0801166
Disease	cardiomyopathy (is_implicated_in)	MYH7 TAB2	4.59e-03	19	158	2	DOID:0050700 (is_implicated_in)
Disease	Hypertriglyceridemia	TDRD15 BAZ1B	4.59e-03	19	158	2	EFO_0004211
Disease	susceptibility to hepatitis B infection measurement	GRIN2A STAU2 DCLK1	4.94e-03	64	158	3	EFO_0008405
Disease	coronary artery disease	TDRD15 DPP6 FAT4 DNAJC13 TAB2 PKD1L3 ABCA8 OPHN1 HIRA SF3B3 CSNK1G2 LMOD1 ACAA2 BICC1	5.04e-03	1194	158	14	EFO_0001645
Disease	Sarcomatoid Renal Cell Carcinoma	DNHD1 RYR1 SYNE2 NAV3	5.05e-03	128	158	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	DNHD1 RYR1 SYNE2 NAV3	5.05e-03	128	158	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	DNHD1 RYR1 SYNE2 NAV3	5.05e-03	128	158	4	C1266044
Disease	Papillary Renal Cell Carcinoma	DNHD1 RYR1 SYNE2 NAV3	5.05e-03	128	158	4	C1306837
Disease	Renal Cell Carcinoma	DNHD1 RYR1 SYNE2 NAV3	5.05e-03	128	158	4	C0007134

Protein segments in the cluster

Peptide	Gene	Start	Entry
ILNTRYGEALFMNSK	TRHDE	946	Q9UKU6
HMASQSGKRYNLTLN	C5orf63	81	A6NC05
RNKELEGSLQQMYST	CDR2L	41	Q86X02
TQRKNFYAGDLLMSV	ADGRB3	606	O60242
IMYARATSGDKLNNN	ADAM10	416	O14672
GSYRSVQEFLTDMKQ	BAZ1B	1396	Q9UIG0
NYQTMSDTTFKALRR	CAPZA1	246	P52907
QELMDSDSGNYLKRA	ANKK1	326	Q8NFD2
RDAAMNGLIKYSISS	FAT4	3116	Q6V0I7
AAANAIRVYLMQTSG	ABCB10	226	Q9NRK6
TSKLFQGQYRSLDMT	ARHGEF7	166	Q14155
KLSSANISYLMGNLE	ARHGEF7	306	Q14155
SQNGRLYSIKSTKML	ANGPTL3	436	Q9Y5C1
RSRYSGVNQSMLFDK	ATAD2	161	Q6PL18
TEESNLNMYTRGKQK	ATAD2	211	Q6PL18
TSLYRQYTSLLGKMN	DIABLO	111	Q9NR28
GSVSSQLQYKRLEMN	DNHD1	4616	Q96M86
TMVNSSNYLDRGILK	DEPDC7	241	Q96QD5
RSQLEAYSTLLANMG	ATXN1	171	P54253
MQYINTASKTGSLKR	DIAPH3	156	Q9NSV4
NISVSFKQRSRMYGA	BICC1	236	Q9H694
KMDTTSDNFGYNLLT	ATP8A2	351	Q9NTI2
DKLSSRIQSMLGNYD	AFF4	46	Q9UHB7
YTLNRQAMGELSELS	PZP	476	P20742
DTLQRNGYDLAKAMS	MTA2	236	O94776
DYKQTGDNLSSMLLE	ODF2L	121	Q9ULJ1
RVRKDMYNDTLNGST	QKI	51	Q96PU8
MYNDTLNGSTEKRSA	QKI	56	Q96PU8
SSLMNRYVTNKFDTQ	RAB9A	21	P51151
SSLMNRYVTNKFDSQ	RAB9B	21	Q9NP90
SDYNPLVMSANLKAA	RIMBP3B	1461	A6NNM3
SDYNPLVMSANLKAA	RIMBP3C	1461	A6NJZ7
SYGTNSALKTLEMRQ	FAM81A	111	Q8TBF8
KDGNALISAMRNYSS	OPHN1	41	O60890
LISAMRNYSSAVQKF	OPHN1	46	O60890
ANHMNSSLLSLYRKG	NVL	116	O15381
ADKSAYLMGLNSADL	MYH7	381	P12883
NGNTYMLLTNATLDR	PCDH12	406	Q9NPG4
SSSNMKRAASLNYLN	KLC4	581	Q9NSK0
TSGNSQREYQLMKLL	ORC4	391	O43929
LSEDGAQLLYKTNMN	KMT2C	1386	Q8NEZ4
SRDNSKNTLYLQMGS	IGHV3-64	91	A0A075B6Q5
KNTLYLQMGSLRAED	IGHV3-64	96	A0A075B6Q5
INYSMLGKILSDNAA	MED12L	991	Q86YW9
MRYNLSAGTIKAVTD	MIS18BP1	666	Q6P0N0
GSDRTIAYENKALML	LGALS3BP	511	Q08380
IRNNNSSRFGKYMDI	MYO1A	151	Q9UBC5
ATQIASGMKYLSSLN	DDR2	691	Q16832
NYTIKIADFGMSRNL	DDR2	721	Q16832
KIMTNRLRSAYNGND	GPC1	461	P35052
MSSQLVRYSADGLLQ	GALNT9	496	Q9HCQ5
LKMTQTQEQDSGLYS	HMCN2	2416	Q8NDA2
SNRAMKGLTTHQYDT	ERVMER34-1	546	Q9H9K5
YRNAIKRTSPSDGAM	GAPVD1	1036	Q14C86
SLYLQMNSLRAGDTA	IGHV3-13	96	P01766
ARYMSINTHLGKEQS	CSNK1G2	216	P78368
SLYNLRGNKSISMSV	KRT4	51	P19013
RDASGMLYNLASAIK	DCLK1	486	O15075
NAMSQSLVLYGASKE	CCDC178	41	Q5BJE1
DISKSRFQRQASTMY	FSIP2	4771	Q5CZC0
DSQFLENAKRLSMYG	EPB41L2	391	O43491
YQQLQKDLSKSMSGR	PFDN6	16	O15212
EKISSYQLKIRGSNM	FAT2	1721	Q9NYQ8
RTNYSLAQSAGLSLM	IL1RAPL1	61	Q9NZN1
EKQSTGVYNREAMLN	LMOD1	56	P29536
MSKRYDGSQQALDLK	NXF1	216	Q9UBU9
RYSSILTSNRVAKMG	OR51A7	131	Q8NH64
NSDISQSYRRMFQAK	MTSS1	551	O43312
LSGNEYVLSTKNTQM	PDE8A	456	O60658
KTQQDMQSSLAARYA	NAV3	216	Q8IVL0
LSVKYMRSLQNSLQG	HES3	41	Q5TGS1
RNMSNYLSLAAITKA	VEPH1	146	Q14D04
KILNYFSTRKNSMGI	DDHD2	436	O94830
ARIRAAKSGSANAYM	KCND2	431	Q9NZV8
LKRSSESMENINSGY	KMT2E	471	Q8IZD2
MQKNVEENLYSSSLG	GLT8D2	251	Q9H1C3
ARGYLQALASKMTEE	CDC42BPB	831	Q9Y5S2
ISAAMYKSLDQAISR	CYFIP2	796	Q96F07
MAYLSRLSAIAGNKI	ARHGAP32	216	A7KAX9
RDVYKASNTMALGVT	GARIN1B	91	Q96KD3
GYTLQKTLSRMSQNL	PHOSPHO2	201	Q8TCD6
LRRDVSSMYNKVTLG	ECEL1	331	O95672
ELSNMASELAKYGLQ	IQGAP3	171	Q86VI3
SQEMSIGKKRNSTLY	IL13RA1	331	P78552
GLSNYNAESSMVSKE	LRRIQ1	686	Q96JM4
MGSENSALKSYTLRE	SCYL3	1	Q8IZE3
DASTKMQGDYTLTLR	PIK3R3	91	Q92569
AGEAKTQSAMLRYSS	PXDNL	311	A1KZ92
LNYIMDTVKDSSNGA	ATM	121	Q13315
SGMAQQRETATKVYD	ATM	1306	Q13315
TSGTMNSYELRLALN	CAPN12	636	Q6ZSI9
ELSFMAAQRNYSQSK	CHD9	1991	Q3L8U1
QRSTETALYRKMLGN	FKBP8	356	Q14318
DNDLMKYSAIQTLDG	IFT43	136	Q96FT9
GSSEALSQYKMNITS	CASD1	176	Q96PB1
LQNGRMSIKAYVSTL	EIF3F	206	O00303
MRNTSKELQGATHRY	C7orf57	1	Q8NEG2
SASMRDLIQGAESYK	GCC2	1006	Q8IWJ2
SMSYNLLGFLQRSSN	IFNB1	21	P01574
GSSYIVSNSANLKVM	CARD8	371	Q9Y2G2
KALKAMTRSLQYGEQ	DNAJC13	2161	O75165
NISYTRNMTLKDGKN	MCCC1	546	Q96RQ3
SEYSAVSRNSLKEMG	INSC	166	Q1MX18
RTFQDLSKQVEMSYG	GRID1	666	Q9ULK0
SRGNTNKFYMLDSRS	KLHDC2	111	Q9Y2U9
YTPAIRANDNKSMAD	AHCTF1	1441	Q8WYP5
IMKAQALRDNSTTGY	HSP90AA4P	301	Q58FG1
QSTYGKSLAIMTEAQ	HIRA	376	P54198
MRLTVAEGKTDNQYT	CD226	236	Q15762
MASLYQRFTGKINTS	DPP6	1	P42658
SLKRYNLGSSAMKRN	BLID	66	Q8IZY5
MTEIYNDLSKNTTGS	ZMYND8	941	Q9ULU4
ERNYNLQMSGETLKT	RYR1	916	P21817
NLSTLQLMGSYTEIR	PKD1L1	1306	Q8TDX9
ISRDDSKNTAYLQMN	IGHV3-73	91	A0A0B4J1V6
ALNKSREFNLMYDGT	IRF6	86	O14896
TRSNLYLMDRSGKAD	NRK	1226	Q7Z2Y5
FKTSMGDLQRQLYNR	GARIN3	21	Q8TC56
DAYLSKAMEIASQRT	RIOK1	396	Q9BRS2
NYSAELRNASAVMKN	RUNX3	116	Q13761
ASKYSGSQMEILANQ	SORL1	986	Q92673
SYSLQLSNLKMEDTG	SLAMF6	91	Q96DU3
LSNLKMEDTGSYRAQ	SLAMF6	96	Q96DU3
TLGKQTAMRTDQYNS	SEMA3F	236	Q13275
ISTSMLGRVKYNLNS	RNASEH2A	101	O75792
AYGKISTSDNSMAQI	SYNE2	4166	Q8WXH0
RKLSMGSDDAAYTQA	TAB2	521	Q9NYJ8
GVKLQVMANSRNYKS	KARS1	151	Q15046
AKEFLMNRGSAQYIT	TDRD15	926	B5MCY1
ENMTELLSSGLKNDY	MKLN1	96	Q9UL63
SDYNPLVMSANLKAA	RIMBP3	1461	Q9UFD9
NELSKRYMVNFVSGS	SAMD9	1221	Q5K651
ILGSDYNTMKENSIA	ODAD2	136	Q5T2S8
SEMSSALLLANYGSK	FYB2	151	Q5VWT5
MFLNTIAGRTYNDLN	NBEA	2301	Q8NFP9
ERLTSKNENGFSYIM	PKD1L3	1426	Q7Z443
MGTARQDVYDLLKTN	PSMD1	486	Q99460
VEGQKSNRKDYSLTM	SIGLEC7	16	Q9Y286
LTISYLKMRDFANQG	NPAS3	96	Q8IXF0
KGSVDQYLLRSSNMA	RNF169	691	Q8NCN4
QKELAQLARMTDGYS	SPAST	531	Q9UBP0
SQLTRGKLSYTQQME	MYH6	1301	P13533
LRQAQAAGVSLSLYM	STARD8	806	Q92502
GNQSRILTQAYKRMA	STK36	296	Q9NRP7
MSSIDDYKNRARSQL	ABCA8	1041	O94911
NYQTMSDTTFKALRR	CAPZA2	246	P47755
SYERAQKEGSIAMQS	CCDC15	106	Q0P6D6
MGNVLQSSSDAIYLA	ACAA2	56	P42765
AAPRQGNMYTLSKDS	XIRP2	3346	A4UGR9
GNMYTLSKDSLSNGV	XIRP2	3351	A4UGR9
QEYQSKKLMSDNGVR	SUCLG2	41	Q96I99
NGESLSMDYIRTKDN	VPS13A	1911	Q96RL7
MATKLSGLQSRYSRV	RBP3	961	P10745
ASTKAMAGSILNSYI	RNF19A	591	Q9NV58
AGKMNISIDLDTNYA	SLFN12L	16	Q6IEE8
AEAMLLQLGYKASTN	STAU2	366	Q9NUL3
AAIYMASQASAEKRT	GTF2B	256	Q00403
SLKISDSQLGDAAMY	TRA	96	P0DTU3
MSDLSAYGSSIQALR	SPTAN1	936	Q13813
LTVMYSQINGASRAL	TRIM25	206	Q14258
MDYGTNLSTDLSLNK	STK10	496	O94804
RLQANMGAKALYVAN	EZH1	31	Q92800
LSATRKNASNMEYRI	NPTN	191	Q9Y639
NLVISASQLGDSAMY	TRAV14DV4	96	A0A0A6YYC5
SGQLNEYTERKEMSA	SF3B3	571	Q15393
YRASMNLSQAFSSLK	TLR7	356	Q9NYK1
AGNSSVEMYRQVLLS	PLCB1	341	Q9NQ66
ESQYQQSMDSKLSGR	SMAP	81	O00193
AASLRQTSEGKYIMS	TSHZ3	911	Q63HK5
LHKSMRGSDQNASLY	WRNIP1	506	Q96S55
KSYMESLRNDQVLQG	UBR3	1336	Q6ZT12
SLKISDSQLGDAAMY	TRAV38-2DV8	96	A0JD32
AQMKRELYNGTADIT	PIEZO1	2286	Q92508
LQGLSSLMYASESKD	TTC39C	251	Q8N584
SSLLRTSIMSKQYGN	CCT8	161	P50990
LMGKRALNSVAYERS	TAC1	106	P20366
RMTVLSTAQSDYNRK	HIVEP1	2256	P15822
ALSYTGSDNIIMASK	ZBTB26	241	Q9HCK0
AKDGAAMYSLINALS	KIAA0586	496	Q9BVV6
SDVMLENYKNLSSVG	ZNF560	136	Q96MR9
SLKISDSQLGDTAMY	TRAV38-1	96	A0A0B4J264
SLYISNGVAANNKLM	DUSP18	26	Q8NEJ0
RASAMNVKGELSAYA	MYOM1	351	P52179
LMYSDNRSFQGKESI	GRIN2A	941	Q12879